Annual CFI
-$6.19 M
+$2.13 M+25.63%
31 March 2024
Summary:
LakeShore Biopharma annual cash flow from investing activities is currently -$6.19 million, with the most recent change of +$2.13 million (+25.63%) on 31 March 2024. During the last 3 years, it has risen by +$9.20 million (+59.77%). LSB annual CFI is now at all-time high.LSB Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$3.24 M
0.00%
30 September 2023
Summary:
LakeShore Biopharma quarterly cash flow from investing activities is currently -$3.24 millionLSB quarterly CFI is now -16.54% below its all-time high of -$2.78 million, reached on 01 September 2022.LSB Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$3.24 M
0.00%
30 September 2023
Summary:
LakeShore Biopharma TTM cash flow from investing activities is currently -$3.24 millionLSB TTM CFI is now -16.54% below its all-time high of -$2.78 million, reached on 01 September 2022.LSB TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LSB Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +25.6% | - | - |
| 3 y3 years | +59.8% | - | - |
| 5 y5 years | - | - | - |
LSB Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +86.7% | -16.5% | at low | -16.5% | at low |
| 5 y | 5 years | at high | +86.7% | -16.5% | at low | -16.5% | at low |
| alltime | all time | at high | +86.7% | -16.5% | at low | -16.5% | at low |
LakeShore Biopharma Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | -$6.19 M(-25.6%) | - | - |
| Sept 2023 | - | -$3.24 M(+16.5%) | -$3.24 M(+16.5%) |
| Mar 2023 | -$8.32 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$2.78 M | -$2.78 M |
| Mar 2022 | -$46.53 M(+202.5%) | - | - |
| Mar 2021 | -$15.39 M | - | - |
FAQ
- What is LakeShore Biopharma annual cash flow from investing activities?
- What is the all time high annual CFI for LakeShore Biopharma?
- What is LakeShore Biopharma annual CFI year-on-year change?
- What is LakeShore Biopharma quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for LakeShore Biopharma?
- What is LakeShore Biopharma TTM cash flow from investing activities?
- What is the all time high TTM CFI for LakeShore Biopharma?
What is LakeShore Biopharma annual cash flow from investing activities?
The current annual CFI of LSB is -$6.19 M
What is the all time high annual CFI for LakeShore Biopharma?
LakeShore Biopharma all-time high annual cash flow from investing activities is -$6.19 M
What is LakeShore Biopharma annual CFI year-on-year change?
Over the past year, LSB annual cash flow from investing activities has changed by +$2.13 M (+25.63%)
What is LakeShore Biopharma quarterly cash flow from investing activities?
The current quarterly CFI of LSB is -$3.24 M
What is the all time high quarterly CFI for LakeShore Biopharma?
LakeShore Biopharma all-time high quarterly cash flow from investing activities is -$2.78 M
What is LakeShore Biopharma TTM cash flow from investing activities?
The current TTM CFI of LSB is -$3.24 M
What is the all time high TTM CFI for LakeShore Biopharma?
LakeShore Biopharma all-time high TTM cash flow from investing activities is -$2.78 M